Candriam SCA’s Sage Therapeutics SAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-222,000
Closed -$4.16M 719
2024
Q1
$4.16M Sell
222,000
-5,000
-2% -$115K 0.03% 372
2023
Q4
$4.92M Hold
227,000
0.03% 336
2023
Q3
$4.67M Hold
227,000
0.03% 314
2023
Q2
$10.7M Buy
227,000
+137,000
+152% +$6.82M 0.08% 237
2023
Q1
$3.48M Buy
+90,000
New +$3.87M 0.02% 451
2021
Q4
Sell
-185,058
Closed -$8.2M 854
2021
Q3
$8.2M Buy
185,058
+46,490
+34% +$2.13M 0.06% 309
2021
Q2
$7.87M Sell
138,568
-6,079
-4% -$430K 0.05% 323
2021
Q1
$12M Hold
144,647
0.1% 222
2020
Q4
$12.5M Sell
144,647
-4,653
-3% -$343K 0.1% 226
2020
Q3
$9.13M Buy
+149,300
New +$7.57M 0.09% 254
2020
Q2
Sell
-149,300
Closed -$5.42M 331
2020
Q1
$10.5M Hold
149,300
0.12% 203
2019
Q4
$10.8M Buy
149,300
+10,000
+7% +$1.23M 0.12% 205
2019
Q3
$19.5M Buy
139,300
+21,000
+18% +$3.51M 0.26% 76
2019
Q2
$21.6M Sell
118,300
-60,000
-34% -$10.2M 0.27% 80
2019
Q1
$28.4M Buy
178,300
+18,000
+11% +$2.61M 0.36% 52
2018
Q4
$15.4M Buy
160,300
+22,500
+16% +$2.57M 0.24% 100
2018
Q3
$19.5M Buy
137,800
+81,400
+144% +$12.6M 0.26% 92
2018
Q2
$8.83M Buy
56,400
+18,400
+48% +$2.89M 0.14% 189
2018
Q1
$6.12M Hold
38,000
0.1% 247
2017
Q4
$6.26M Sell
38,000
-16,000
-30% -$1.55M 0.11% 226
2017
Q3
$3.36M Sell
54,000
-9,000
-14% -$707K 0.06% 351
2017
Q2
$5.02M Sell
63,000
-10,000
-14% -$723K 0.09% 261
2017
Q1
$5.19M Buy
73,000
+41,000
+128% +$2.4M 0.1% 244
2016
Q4
$1.63M Sell
32,000
-7,000
-18% -$330K 0.04% 406
2016
Q3
$1.8M Sell
39,000
-35,000
-47% -$1.42M 0.04% 378
2016
Q2
$2.23M Buy
74,000
+5,000
+7% +$167K 0.06% 291
2016
Q1
$2.2M Sell
69,000
-7,200
-9% -$253K 0.06% 308
2015
Q4
$4.44M Buy
76,200
+10,000
+15% +$495K 0.12% 195
2015
Q3
$2.8M Sell
66,200
-5,800
-8% -$357K 0.07% 297
2015
Q2
$5.26M Sell
72,000
-7,000
-9% -$450K 0.11% 233
2015
Q1
$3.97M Buy
79,000
+14,000
+22% +$602K 0.08% 291
2014
Q4
$2.38M Buy
+65,000
New +$2.42M 0.05% 336

Other funds holding SAGE